PTPN7
Tyrosine-protein phosphatase non-receptor type 7
Also known as: HEPTP, LC-PTP, PTN7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35236
- Gene
- PTPN7
- Ensembl
- ENSG00000143851
- Chromosome
- 1
- Canonical length
- 360 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Microtubules,Mitotic spindle,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This gene is preferentially expressed in a variety of hematopoietic cells, and is an early response gene in lymphokine stimulated cells. The non-catalytic N-terminus of this PTP can interact with MAP kinases and suppress the MAP kinase activities. This PTP was shown to be involved in the regulation of T cell antigen receptor (TCR) signaling, which was thought to function through dephosphorylating the molecules related to MAP kinase pathway. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
360 residues, UniProt reviewed canonical sequence.
>P35236|PTPN7
1 MVQAHGGRSR AQPLTLSLGA AMTQPPPEKT PAKKHVRLQE RRGSNVALML DVRSLGAVEP
61 ICSVNTPREV TLHFLRTAGH PLTRWALQRQ PPSPKQLEEE FLKIPSNFVS PEDLDIPGHA
121 SKDRYKTILP NPQSRVCLGR AQSQEDGDYI NANYIRGYDG KEKVYIATQG PMPNTVSDFW
181 EMVWQEEVSL IVMLTQLREG KEKCVHYWPT EEETYGPFQI RIQDMKECPE YTVRQLTIQY
241 QEERRSVKHI LFSAWPDHQT PESAGPLLRL VAEVEESPET AAHPGPIVVH CSAGIGRTGC
301 FIATRIGCQQ LKARGEVDIL GIVCQLRLDR GGMIQTAEQY QFLHHTLALY AGQLPEEPSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTPN7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 71 nTPM
Expression across tissuesHPA
Tissue
- thymus: 71 nTPM
- bone marrow: 65 nTPM
- tonsil: 51 nTPM
- lymph node: 47 nTPM
- appendix: 25 nTPM
- spleen: 14 nTPM
Single-cell type
- nk-cells: 127 nCPM
- t-cells: 122 nCPM
- neutrophil progenitors: 118 nCPM
- mast cells: 109 nCPM
- innate lymphoid cells: 97 nCPM
- sertoli cells: 79 nCPM
Immune cell
- gdT-cell: 47 nTPM
- T-reg: 46 nTPM
- memory CD8 T-cell: 45 nTPM
- NK-cell: 40 nTPM
- MAIT T-cell: 36 nTPM
- basophil: 36 nTPM
Brain region
- basal ganglia: 22 nTPM
- thalamus: 7.4 nTPM
- white matter: 7.3 nTPM
- medulla oblongata: 6 nTPM
- pons: 4.4 nTPM
- midbrain: 4.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.2
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTPN7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTPN7 as an antibody target. Whether an autoantibody or antibody against PTPN7 could matter depends on whether native PTPN7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTPN7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTPN7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...